RedChip Investor Webinar with Calidi Biotherapeutics (NYSE American: CLDI)

Calidi Biotherapeutics is a clinical-stage biotechnology company advancing the next generation of targeted immunotherapies through its innovative systemic delivery platform, RedTail. Leveraging over a decade of scientific expertise, Calidi has developed an engineered enveloped vaccinia virus uniquely designed to evade immune clearance, selectively target metastatic tumor sites, and deliver potent genetic payloads directly within the tumor microenvironment.